Planning

NHS National Generics Pharmaceuticals - Supply Chain Resilience

  • NHS England

UK2: Preliminary market engagement notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2026/S 000-005168

Procurement identifier (OCID): ocds-h6vhtk-060abf (view related notices)

Published 21 January 2026, 10:56am



Scope

Reference

CM/PHG/25/5739

Description

NHS National Generics Pharmaceuticals - Supply Chain Resilience

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

Periods of call-offs under the framework agreement:

CM/PHG/25/5739/01 - Orals (plus non-parenteral) Products

CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months)

NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months)

LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)

CM/PHG/25/5739/02 - Hospital Only Products

DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months)

DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months)

DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)

Commercial tool

Establishes a framework

Total value (estimated)

  • £52,447,296 excluding VAT
  • £62,936,755 including VAT

Contract dates (estimated)

  • 1 September 2026 to 31 May 2028
  • Possible extension to 31 August 2030
  • 4 years

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products

Engagement

Engagement deadline

28 January 2026

Engagement process description

NHS England is advising suppliers of an upcoming tender for the NHS National Generics Pharmaceuticals - Supply Chain Resilience, to commence on 1st September 2026 for varying dates of up to 21 months with options to extend for a maximum total contract period of 48 months. This procurement will largely consist of previously terminated products of hospital only and oral (plus non-parenteral) products across all regions of the country. The purpose of this notice is to inform existing and potential new suppliers of this procurement. Useful information for suppliers can be found here www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ . Specific information regarding the products included in this procurement will be provided in the ITO which will be issued shortly.


Participation

Particular suitability

Small and medium-sized enterprises (SME)


Submission

Publication date of tender notice (estimated)

30 January 2026


Contracting authority

NHS England

  • Public Procurement Organisation Number: PDPT-3135-BWWY

Wellington House, 133-135 Waterloo Rd

London

SE1 8UG

United Kingdom

Region: UKI45 - Lambeth

Organisation type: Public authority - central government